QuantalX Receives FDA Breakthrough Designation for Diagnosis of Normal Pressure Hydrocephalus and Prediction of Treatment Response
Menu

19.09.2023

QuantalX Neuroscience Ltd.

QuantalX Receives FDA Breakthrough Designation for Diagnosis of Normal Pressure Hydrocephalus and Prediction of Treatment Response

https://quantalx.com/quantalx-receives-fda-breakthrough-designation-for-diagnosis-of-normal-pressure-hydrocephalus-and-prediction-of-treatment-response/

Exhibitor Data Sheet